Pfizer nabbed a $5.4 billion deal to acquire sickle cell drugmaker Global Blood Therapeutics, according to an Aug. 8 press release.
Read the full post on Becker's Hospital Review - Healthcare News
Pfizer to acquire Global Blood Therapeutics for $5.4B
